Phew! Johnson & Johnson’s Q1 Profits up 8% DESPITE Billions in Lawsuits
Johnson & Johnson Q1 profits are up 8% in part because of new drugs and cutting production and administrative expenses (does that mean job loss for people?) despite:
I’d imagine there are more than a few victims of the Johnson & Johnson vaginal mesh trials are happy to hear about Johnson & Johnson 8% profits for Q1.
The world’s biggest maker of healthcare products beat Wall Street expectations and raised its earnings outlook Tuesday. The maker of the Band-Aid and biologic drugs said net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier.
“Consumer products … will stay weak because consumers learned there is nothing special about” J&J’s, said Erik Gordon, an analyst at University of Michigan’s business school.
Did some of us learn something new about Johnson & Johnson? If you did and aren’t happy with what you read please join the campaign to hold Johnson & Johnson executives accountable to the public or Boycott the Band-Aid, click on any of the links above to join campaigns to hold Johnson & Johnson accountable.
And for more information visit : Johnson & Toxin